SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q


þ		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED ~~December~~March 31, ~~2008~~2009 or


o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 000-53487

Valiant Healthcare, Inc.

(Exact name of registrant as specified in its charter)

Delaware		No. 26-2871644
Delaware (State or other jurisdiction		No. 26-2871644 (I.R.S. Employer Identification No.)
(State or other jurisdiction		(I.R.S. Employer Identification No.)
of incorporation or organization)
210 N. University Drive, Suite 810, Coral Springs, Florida		33071
210 N. University Drive, Suite 810, Coral Springs, Florida (Address of principal executive offices)		33071 (Zip Code)
(Address of principal executive offices)		(Zip Code)

(954) 419-1835
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes o No þ

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer o	Accelerated filed o	Non-accelerated filer o	Smaller reporting company þ
		(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes þ No o

As of ~~March~~May 35, 2009, the Registrant had 111,~~000~~950,000 shares of its common stock outstanding.

INDEX

	Page Number
Part I. FINANCIAL INFORMATION:
Item 1. Unaudited Financial Statements
Balance Sheet— As of December 31, 2008		3
Balance Sheet— As of March 31, 2009		3
Statement of Operations — For the Three Months Ended December 31, 2008 and for the cumulative period from inception (June 24, 2008) to December 31, 2008		4
Statement of Operations — For the Three Months Ended March 31, 2009 and for the cumulative period from inception (June 24, 2008) to March 31, 2009		4
Statements of Stockholder’s Equity — For the cumulative period from inception (June 24, 2008) to December 31, 2008		5
Statements of Stockholder’s Equity — For the cumulative period from inception (June 24, 2008) to March 31, 2009		5
Statements of Cash Flows — For the cumulative period from inception (June 24, 2008) to December 31, 2008		6
Statements of Cash Flows — For the cumulative period from inception (June 24, 2008) to March 31, 2009		6
Notes to Financial Statements		7
Item 1A. Risk Factors		9
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		1112
Item 3. Quantitative and Qualitative Disclosures about Market Risk		1516
Item 4. Controls and Procedures		1516
Part II. OTHER INFORMATION:
Item 1. Legal Proceedings		1617
Item 6. Exhibits and Reports on Form 8-K		1617
SIGNATURES		1718
Exhibit 31.1
Exhibit 32

ITEM 1. FINANCIAL STATEMENTS

Valiant Healthcare, Inc.

a development stage company

Balance Sheet ~~December 31, 2008~~

Assets
Current Assets
Cash	$	7,500
Total Assets	$	7,500
Liabilities
Accounts payable and accrued expenses	$	5,000
Total Liabilities		5,000
Stockholder’s Equity:
Common Stock, 100,000,000 shares authorized 1,000,000 shares @ $.0001 par issued and outstanding	$	1,000
Additional Paid in Capital		6,500
(Deficit) Accumulated During Development Stage		(5,000	)
Total Stockholder’s Equity	$	2,500
Total Liabilities and Stockholder’s Equity	$	7,500

March 31, 2009


Assets
Current Assets
Cash	$	7,500


Total Assets	$	7,500


Liabilities
Accounts payable and accrued expenses	$	5,000


Total Liabilities		5,000

Stockholder’s Equity:
Common Stock. 100,000,000 shares authorized 1,000.000 shares @ .001 par issued and outstanding	$	1,000
Additional Paid in Capital		6,500
(Deficit) Accumulated During Development Stage		(5,000	)


Total Stockholder’s Equity	$	2,500


Total Liabilities and Stockholder’s Equity	$	7,500

The accompanying notes are an integral part of these financial statements.

Valiant Healthcare, Inc. a development stage company

aStatement ~~development~~of ~~stage company~~ Operations

~~Statement of Operations~~ For the ~~three~~Three month period ended ~~December~~March 311, ~~2008~~2009 and for the cumalative period from inception (June 24, 2008) ~~to December 31, 2008~~

	For the three		From Inception
	For 3 mths.		From Inception
	months ending		(June 24, 2008)
	ending		(June 24, 2008)
	Dec. 31, 2008		to ~~December~~Dec. 31, 2008
Revenues	$	—	$	—
Cost and expenditures
Professional fees	$	—0.00	$	5,000
Total costs and expenses	$	—0.00		5,.000
Provision for Income Taxes
Provision for income Taxes
Net loss	$	—	$	(5,000	)
Weighted Average of Shares Outstanding		1,000,000		1,000,000
Loss per share, basic	$	—	$	(.005)	)

The accompanying notes are an integral part of these financial statements.

Valiant Healthcare, Inc. a development stage company

aStatement ~~development~~of ~~stage~~Stockholder’s ~~company~~ Equity

~~Statement of Stockholder’s Equity~~ For the Period from Inception (June 24, 2008) to ~~June~~March 3031, ~~2008~~2009

									Deficit
	Common		Par
	Common		Par						Accumulated during
	Stock		Value		Total		APIC		Deficit Accumulated during development stage			Total
	Stock		Value		Total		APIC		development stage			Total
Balance, Beginning		—	$	—	$	—	$	—		—		$	—
Isuance of Shares-Founder for cash June 24, 2008, $0.0075/share		5,000,000		0.001		5,000		2,500		—			7,500
Loss for the initial period		—		—		—		—		(5,000	)		(5,000	)
Balance, Ending		5,000,000	$	0~~.0001~~,001	$	5,000	$	2,500		(5,000	)		(2,500	)

The accompanying notes are an integral part of these financial statements.

Valiant Healthcare, Inc.

a development stage company

Statement of Cash Flows ~~December 31, 2008~~

Cash Flows from operating activities:
Net Loss for the period	$	(5,000	)
Net Increase in accounts payable		5,000
Cash Flows from Financing Activities
Sale of Common Stock		7,500
Net Increase in Cash		7,500
Cash at the beginning		—
Cash at the end	$	7,500
Supplemental Information

March 31, 2009


Cash Flows from operating activities:
Net Loss for the period	$	(5,000	)
Net increase in accounts payable		5,000
Cash Flows from Financing Activities
Sale of Common Stock		7,500


Net Increase in Cash		7,500

Cash at the beginning		—


Cash at the end	$	7,500

Supplemental information

The accompanying notes are an integral part of these financial statements.

Valiant Healthcare, Inc.

Notes to Financial Statements

~~December~~Ending period March 31, ~~2008~~2009 Dated April 28, 2009

NOTE 1 — ORGANIZATION

Organization and Line of Business

Valiant Healthcare, Inc. (the “Company”) is currently a blank check company under the provisions of Statement of Financial Accounting Standards (“~~SFAS~~SPAS”) No. 7 and was incorporated under the laws of the State of Delaware on June 24, 2008. The Company’s purpose is to raise capital that is intended to be used in connection with its business plans which may include a possible merger, acquisition or other business combination with an operating business.

The Company should be considered a development stage company. As of ~~December 31~~April 1, ~~2008~~2009 the ~~has~~company ~~not~~has entered in to ~~nay~~an ~~business~~agreement ~~activity~~to acquire Accessible Home Health Care from Accessible Healthcare Services, Inc.

NOTE 2 — SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation/Going Concern

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has no established source of revenue. This matter raises substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Management plans to take the following steps that it believes will be sufficient to provide the Company with the ability to continue in existence:

Management intends to raise financing through private equity financing or other means and interests that it deems necessary.

As of ~~December~~March 31, ~~2008~~2009 the company has not raised any equity financing.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles require management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting periods. Actual results could differ from these estimates.

Fair Value of Financial Instruments

The estimated fair values of cash, property and equipment and due to stockholder, none of which are held for trading purposes, approximate their carrying value because of the short term maturity of these instruments or the stated interest rates are indicative of market interest rates.

Valiant Healthcare, Inc. Notes to Financial Statements ~~June~~March 3031, ~~2008~~2009

NOTE 2 — SIGNIFICANT ACCOUNTING POLICIES (Continued)

Income Taxes

The Company follows the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. A valuation allowance is recorded to reduce the carrying amounts of deferred tax assets unless management believes it is more likely than not that such assets will be realized.

Basis and Diluted ~~Income~~lncome/(Loss) Per Share:

In accordance with SFAS No. 128, “Earnings Per Share,” the basic income/(loss) per common share is computed by dividing net income/(loss) available to common stockholders by the weighted average number of common shares outstanding. Diluted income per common share is computed similar to basic income per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.

Revenue Recognition

Revenue is recognized in accordance with SEC Staff Accounting Bulletin No. 101, “Revenue Recognition in Financial Statements”. The Company recognizes revenue when the significant risks and rewards of ownership have been transferred to the customer pursuant to ~~applicable~~ applicabie laws and regulations, including factors such as when there has been evidence of a sales arrangement, the performance has occurred, or service have been rendered, the price to the buyer is fixed or determinable, and collectability is reasonably assured.

NOTE 3 — STOCKHOLDER’S EQUITY

The Company has issued 1,000,000 shares of its common stock as founder shares, for a total consideration of $7,500, for a per share price of $0.0075.

ITEM 1A. RISK FACTORS

The business of Valiant is subject to numerous risk factors, including, ~~the~~but not limited to, the following:

~~Valiant~~We ~~has~~may nonot ~~operating~~be ~~history~~profitable nor revenue and minimal assets and operates at a loss. Valiant has had no operating history nor any revenues or earnings from operations. Valiant has no significant assets or financial resources. Valiant has sustained losses to date and will, in ~~all likelihood, continue to sustain expenses without corresponding revenues, at least until~~ the ~~consummation~~ ~~of a business combination~~future. ~~Valiant anticipates that the costs of seeking,~~ investigating and analyzing potential business combinations over the next 12 months will be paid with current funds or with such additional amounts from the sale of its securities or that it may be able to borrow.

~~Valiant~~While ~~has~~the ~~only~~related ~~one~~entity ~~director~~from ~~and~~which ~~one~~we ~~officer.~~only ~~The~~recently ~~sole~~purchased ~~officer~~the ~~and~~assets ~~director~~for ofAccessible ~~Valiant is~~Home ~~Steven~~Health ~~Turner.~~Care ~~Because~~was ~~management~~profitable ~~consists~~in ofthe ~~only one person~~past, ~~Valiant~~we ~~does~~may not ~~benefit~~be ~~from multiple~~profitable ~~judgments~~in ~~that~~the afuture ~~greater~~as ~~number~~we ofoperate ~~directors~~these assets and other assets or ~~officers~~entities ~~would~~that ~~provide~~we ~~and~~might ~~Valiant~~purchase. ~~will rely~~Since ~~completely~~we onwere ~~the~~only ~~judgment~~formed ofin ~~its~~June 2008, ~~sole~~we ~~officer~~have incurred start-up and ~~director~~other ~~when~~expenses ~~selecting~~and ahave ~~target~~incurred ~~company~~losses as a result. We ~~Mr. Turner~~acquired ~~anticipates~~these ~~devoting~~operating ~~only~~assets from a ~~limited~~related ~~amount~~entity ofon ~~time~~April 1, to2009 ~~the~~and ~~business~~expect ofthat ~~Valiant. Mr.~~our ~~Turner~~continued ~~has~~operation ~~not~~of ~~entered~~those ~~into~~assets awill ~~written~~allow ~~employment~~us ~~agreement~~to ~~with~~be ~~Valiant~~profitable. ~~Valiant~~However, ~~has~~there ~~not~~is ~~obtained~~no guarantee ~~key~~that ~~man~~we ~~life~~will ~~insurance~~be profitable, either on ~~Mr. Turner.~~a ~~The~~quarterly ~~loss~~or ofyearly ~~his~~basis ~~services~~as ~~would~~we ~~adversely~~move ~~affect~~forward ~~development of~~with the newly-acquired ~~business~~operating ofassets ~~Valiant~~as ~~and~~well ~~its~~as ~~likelihood~~any ofother ~~commencing~~business ~~operations~~combinations we might undertake.

~~Conflicts~~We ofwill ~~interest.~~require ~~Mr. Turner,~~additional ~~the~~capital ~~president~~either offrom ~~Valiant, participates in other business ventures which may compete with Valiant. Additional conflicts of interest and non-arms length transactions may also arise in~~ the ~~future.~~sale ~~The certificate~~ of ~~incorporation~~debt ~~of Valiant provides that Valiant may indemnify officers and/~~or ~~directors~~equity ~~of Valiant for liabilities~~securities, which ~~can~~we ~~include~~may ~~liabilities arising under the securities laws. Assets of Valiant could~~ be ~~used~~unable ~~or attached~~ to ~~satisfy~~ ~~any~~obtain, ~~liabilities subject~~ to ~~such~~fund ~~indemnification~~our expansion.

~~The~~We ~~proposed~~will ~~operations~~need ofa ~~Valiant~~significant ~~are~~amount ~~speculative. The success~~ of ~~the~~additional ~~proposed~~capital ~~business plan of Valiant will depend~~ to afund ~~great~~our ~~extent~~growth ~~on the operations, financial condition~~ and ~~management~~implement ofour ~~the~~business ~~identified target companies~~plan. ~~While~~Additional ~~business~~capital ~~combinations~~may ~~with~~not ~~entities~~be ~~having~~available ~~established operating~~on ~~histories~~acceptable ~~are preferred~~terms, ~~there~~or ~~can~~at beall, noand ~~assurance~~the failure ~~that~~to ~~Valiant~~obtain ~~will~~any besuch ~~successful~~required ~~in locating~~capital ~~candidates~~would ~~meeting~~have ~~such~~a ~~criteria.~~material ~~The~~adverse ~~decision~~effect toon ~~enter~~the ~~into~~short ~~a business combination will~~term ~~likely~~growth beand ~~made~~implementation ~~without~~of ~~detailed~~our ~~feasibility~~business ~~studies,~~plan. ~~independent~~The ~~analysis,~~issuance ~~market~~of ~~surveys~~additional ~~or similar~~equity ~~information which~~capital, if ~~Valiant had more funds available to it~~ needed, would beresult ~~desirable.~~in ~~There~~dilution ~~is no~~of ~~assurance~~the ~~that~~then ~~Valiant~~current ~~can~~stockholder ~~identify~~voting ~~a target company~~ and ~~consummate~~ownership ~~a business combination~~interests.

~~Possible classification as a penny stock. In the event that a public market develops for the securities of~~ Valiant ~~following~~has a ~~business~~very ~~combination,~~limited ~~such~~operating ~~securities~~history ~~may be classified as a penny stock depending upon their market price~~ and ~~the~~only ~~manner~~recently inacquired ~~which~~assets ~~they are traded. The Securities and Exchange Commission has adopted Rule15g-9 which establishes the definition of a “penny stock”, for purposes relevant to Valiant, as any equity security~~ that ~~has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share whose securities~~ are ~~admitted to quotation but do not trade on the Nasdaq Capital Market or on a national securities~~operating ~~exchange.~~assets For any transaction involving a penny stock, unless exempt, the rules require delivery by the broker of a document to investors stating the risks of investment in penny stocks, the possible lack of liquidity, commissions to be paid, current quotation and ~~investors’~~will ~~rights~~produce ~~and remedies, a special suitability inquiry, regular reporting to the investor and other requirements~~revenues.

~~There is a scarcity of and competition for business opportunities and combinations.~~ Valiant ~~is and~~has ~~will~~had ~~continue~~a tovery belimited anoperating ~~insignificant participant in the business of seeking business combinations of business entities~~history. AIn ~~large~~addition, ~~number~~it ofwas ~~established~~only ~~and~~on ~~well-financed entities~~April 1, 2009 ~~including~~that ~~venture~~we ~~capital~~consummated ~~firms,~~a ~~are~~transaction ~~active~~by ~~in business combinations of companies~~ which ~~may~~we ~~be target~~acquired ~~candidates~~operating ~~for~~assets ~~Valiant.~~that ~~Nearly~~will ~~all~~produce ~~such entities have significantly greater financial~~ongoing ~~resources,~~revenues. ~~technical~~Prior ~~expertise~~to ~~and~~that ~~managerial capabilities than Valiant and~~acquisition, ~~consequently,~~ Valiant ~~will~~ behad atno asignificant ~~competitive~~assets ~~disadvantage~~or infinancial ~~identifying possible business opportunities and successfully completing a business combination~~resources. ~~Moreover,~~ Valiant ~~will~~has ~~also~~sustained ~~compete~~losses ~~with~~to ~~numerous other small public companies in seeking business combination candidates~~date.

Operating results are affected by general economic conditions and are subject to quarterly and seasonal fluctuations.

Valiant may experience significant fluctuations in its future quarterly operating results due to a variety of factors, many of which are outside of its control. Factors that may adversely affect our quarterly operating results include, without limitation, (1) our ability to retain existing franchisees, attract new franchisees at a steady rate and maintain franchisee satisfaction, (2) the announcement or introduction of new services and products by either us or our competitors, (3) price competition in the industry, (4) the level of use of home health care services, (5) our ability to upgrade and develop its systems and infrastructure and attract new personnel in a timely and effective manner, (6) the amount and timing of operating costs and capital expenditures relating to expansion of our business, operations and infrastructure, (7) governmental regulation, and (8) general economic conditions and economic conditions specific to the home health care market.

We may not be able to identify or consummate the acquisitions we consider part of our current business plan, which could slow or restrict our growth strategy.

In our very limited history since incorporation, we have consummated one asset acquisition, which only closed on April 1, 2009. In the future, we intend to seek acquisition candidates in selected markets and from time to time will engage in exploratory discussions with suitable candidates. There can be no assurance, however, that we will be able to identify and acquire targeted businesses or obtain financing for such acquisitions on satisfactory terms. The process of integrating acquired businesses into our operations may result in unforeseen difficulties and may require a disproportionate amount of resources and management attention. In connection with future acquisitions, we may incur significant charges to earnings as a result of, among other things, the write-off of purchased assets or for other reasons. Future acquisitions may be financed through the issuance of our common stock, which may dilute the ownership of current stockholders, or through the incurrence of additional indebtedness. Furthermore, there can be no assurance that competition for acquisition candidates will not escalate, thereby increasing the costs of making acquisitions or making suitable acquisitions unattainable.

There is nocompetition ~~agreement~~ for athose ~~business~~private ~~combination~~companies ~~and~~suitable ~~no minimum requirements~~ for ~~business combination.~~transactions As of the ~~date~~type ~~of this report, Valiant had no current arrangement, agreement or~~contemplated ~~understanding~~by ~~with respect to engaging in a business combination with a specific entity~~management. ~~When, if~~ at all, Valiant enters into a business combination it will file the required reports with the Securities and Exchange Commission. There can be no assurance that Valiant will be successful in identifying and evaluating suitable business opportunities or in concluding a business combination. Valiant has not established a specific length of operating history or a specified level of earnings, assets, net worth or other criteria which it will require a target company to have achieved, or without which Valiant would not consider a business combination with such business entity. Accordingly, Valiant may enter into a business combination with one or more business entities having no significant operating history, losses, limited or no potential for immediate earnings, limited assets, negative net worth or other negative characteristics. There is no assurance that Valiant will be able to negotiate a business combination on terms favorable to Valiant.

~~Shareholders~~We ~~may~~are ~~not~~in ~~have~~ a ~~vote~~highly incompetitive ~~approving~~market for a ~~business~~small ~~combination.~~number ~~Valiant~~of ~~intends~~business toopportunities ~~enter~~which could ~~into~~reduce athe ~~business~~likelihood ~~combination,~~of inconsummating ~~the~~successful ~~form~~business ofcombinations ~~(i) a~~we ~~merger~~are ofconsidering ~~another~~in ~~company~~order to ~~into~~expand ~~Valiant,~~our ~~(ii) an acquisition~~business. byWe ~~Valiant~~are ofand ~~all~~will orcontinue ~~substantially~~to ~~all~~be ofan ~~the~~insignificant ~~stock~~participant in the business of ~~another~~seeking ~~company~~mergers with, orjoint ~~(iii) an acquisition~~ventures bywith ~~Valiant~~and acquisitions of ~~all~~small orprivate ~~substantially~~and ~~all~~public ofentities. A ~~the~~large ~~assets~~number of ~~another~~established ~~company,~~and ~~structured pursuant~~well-financed toentities, ~~Delaware~~including ~~law~~small inpublic ~~such~~companies aand venture ~~manner~~capital ~~that~~firms, ~~will~~are ~~not~~active ~~require~~in amergers ~~vote~~and acquisitions of ~~shareholders.~~companies Inthat ~~such cases~~may ~~shareholders should~~ be ~~aware~~desirable target ~~that~~candidates ~~they~~for ~~will~~us. ~~not~~Nearly ~~have~~all athese ~~voice~~entities inhave ~~effecting~~significantly ~~such~~greater afinancial ~~business~~resources, ~~combination~~technical expertise and ~~that~~managerial ~~Valiant~~capabilities ~~may~~than ~~effect~~we ado; ~~business~~consequently, ~~combination~~we ~~without~~will ~~prior~~be ~~shareholder~~at ~~consent.~~a ~~Notwithstanding~~competitive ifdisadvantage ~~under~~in ~~Delaware~~identifying ~~law~~possible ~~any~~business ~~aspect~~opportunities ofand successfully completing a business combination. ~~requires~~These ~~shareholder vote,~~competitive ~~Valiant~~factors ~~will~~may ~~obtain~~reduce ~~such~~the ~~vote~~likelihood of our identifying and consummating a successful business combination.

~~Reporting~~Our ~~requirements~~ability ~~may delay or preclude business combination. Pursuant~~ to ~~the requirements~~operate ofeffectively ~~Section 13~~could of the Securities Exchange Act of 1934, as amended, Valiant is required to provide certain information about significant business combination including audited financial statements of the target company. The additional time and costs that may be ~~incurred~~impaired byif ~~some potential~~we ~~target~~were ~~companies~~ to ~~prepare~~lose such financial statements may significantly delay or essentially preclude consummation of an otherwise desirable business combination by Valiant. Target companies that do not have or are unable to obtain the ~~required~~services ~~audited statements may not be appropriate for a business combination so long as the reporting requirements~~ of ~~the~~our ~~Exchange Act~~key ~~are applicable. Notwithstanding a target company’s agreement to obtain audited financial statements within the required time frame~~personnel, ~~such~~or ~~audited~~if ~~financial~~we ~~statements may not be available to Valiant at the time of entering into an agreement for a business combination. In cases where audited financial statements~~ are ~~unavailable,~~unable ~~Valiant will have~~ to ~~rely~~recruit ~~upon~~qualified ~~information~~managers ~~that~~and ~~has~~key ~~not~~personnel ~~been verified by outside auditors~~ in ~~making its decision to engage in a transaction with~~ the ~~business entity~~future. ~~This risk increases the prospect that a business combination with such a target company~~ ~~might prove to be an unfavorable one for Valiant.~~

~~Regulation~~Our ~~under~~success ~~Investment~~depends ~~Company~~to ~~Act.~~a Insignificant extent on the ~~event~~skills ~~Valiant~~and ~~engages~~efforts inof ~~business~~our ~~combinations~~executive ~~which~~management ~~result~~team inand ~~Valiant~~our ~~holding~~consultants, ~~passive~~including, ~~investment~~but ~~interests~~not inlimited ato, ~~number~~Aarif ~~of entities~~Dohad, ~~Valiant~~Mirella ~~could~~Salem and beSteven ~~subject~~Turner. toWe ~~regulation~~currently ~~under~~do ~~the~~not ~~Investment~~maintain ~~Company~~“key ~~Act~~man” life insurance for any of ~~1940~~these individuals. As ~~Passive~~of ~~investment~~the ~~interests~~date of this report, ~~as used~~we inhave ~~the~~not ~~Investment~~entered ~~Company~~into ~~Act~~any employment agreements. Therefore, ~~essentially~~our employees ~~means~~may ~~investments~~voluntarily ~~held~~terminate bytheir ~~entities~~employment ~~which~~with dous ~~not~~at any time. Our success depends on ~~provide~~our ~~management~~ability orto ~~consulting~~attract ~~services~~and orretain ~~are~~additional ~~not~~qualified ~~involved~~employees inand ~~the~~we ~~business~~believe ~~whose~~that ~~securities~~our ~~are~~future ~~held.~~success Inwill ~~such~~depend ~~event,~~in ~~Valiant~~part ~~would~~upon beour ~~required~~ability to ~~register~~attract asand anretain ~~investment~~additional ~~company~~qualified personnel. Competition for such personnel is intense and ~~could~~we bewill compete for qualified personnel with numerous ~~expected~~other toemployers, ~~incur~~some ~~significant~~of ~~registration~~whom have greater financial and ~~compliance~~other ~~costs.~~resources ~~Valiant~~than ~~has~~we ~~obtained~~do. noIn ~~formal~~addition, ~~determination~~we ~~from~~may ~~the~~incur ~~Securities~~significantly ~~and~~increased ~~Exchange~~costs ~~Commission~~in asorder to ~~the~~attract ~~status~~and ofretain ~~Valiant~~skilled ~~under~~employees. ~~the~~We ~~Investment~~cannot ~~Company~~assure ~~Act~~that ofwe ~~1940~~will be able to attract and retain key personnel. ~~Any~~The ~~violation~~loss of ~~such~~one ~~Act~~or ~~could~~more key ~~subject~~personnel ~~Valiant~~could tohave a material adverse ~~consequences~~ effect on us.

~~Possible~~Our ~~change in value of shares upon~~ business ~~combination.~~is Asubject ~~business~~to ~~combination~~extensive ~~normally will~~government ~~involve~~regulation ~~the~~and ~~issuance of a significant number of additional shares~~supervision. ~~Depending upon the value of~~ ~~the assets acquired in such business combination, the per share value of the common stock of Valiant may increase or decrease, perhaps significantly.~~

Many aspects of our business are presently subject to extensive federal, state and local governmental regulations, including a requirement typically that our franchisees be licensed in order to operate. The failure to obtain licenses could prevent our franchisees from fully operating their businesses and could subject us and/or our franchisees to civil and/or criminal penalties. Obtaining the necessary licenses for our franchisees typically takes a significant amount of time and resources, with no guarantee that such license can be obtained in the end.

We believe we and/or our franchisees currently have all necessary licenses and approvals required for our existing operations in the states where operations are currently conducted. Nevertheless, there can be no assurance that our or our franchisees current or planned operations will meet licensure or other regulatory requirements, nor that such failure would not have a material adverse impact on our financial position or results of operation. Similarly, depending on the nature and extent of any new laws and/or regulations, or possible changes in the interpretation of existing laws and/or regulations, any such changes could have a material adverse effect on the our or their financial condition and/or results of operations.

~~Taxation.~~Our ~~Federal~~industry ~~and~~is ~~state~~very ~~tax~~competitive consequences will, in all likelihood, be major considerations in any business combination Valiant may undertake. Currently, such transactions may be structured so as to result in tax- free treatment to both companies, pursuant to various federal and ~~state~~many tax provisions. Valiant intends to structure any business combination so as to minimize the federal and state tax consequences to both Valiant and the target company; however, there can be no assurance that such business combination will meet the statutory requirements of aour ~~tax-free~~competitors reorganization or that the parties will obtain the intended tax-free treatment upon a transfer of stock or assets. A non-qualifying reorganization could result in the imposition of both federal and state taxes which may have angreater ~~adverse~~resources ~~effect~~than onwe ~~both parties to the transaction~~do.

The home health care market is rapidly evolving and intensely competitive. We expect competition to persist and intensify in the future from existing competitors and companies that enter our existing or future markets. Barriers to entry into the home health care market are relatively low, although we believe that the sophistication of our business and system will give us a competitive advantage over our competitors.

Many of our competitors and potential competitors have longer operating histories, more customers, greater brand recognition and substantially greater financial and other resources than we do. Our competitors may receive investments from or establish commercial or other business relationships with larger, well-financed companies. In addition, our competitors may be able to respond more quickly to changes in customer preferences, spend more on marketing and promotional campaigns, adopt more aggressive pricing policies and devote more resources to developing their businesses.

Possible classification as a penny stock. In the event that a public market develops for the securities of Valiant following a business combination, such securities may be classified as a penny stock depending upon their market price and the manner in which they are traded. The Securities and Exchange Commission has adopted Rule15g-9 which establishes the definition of a “penny stock”, for purposes relevant to Valiant, as any equity security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share whose securities are admitted to quotation but do not trade on the Nasdaq Capital Market or on a national securities exchange. For any transaction involving a penny stock, unless exempt, the rules require delivery by the broker of a document to investors stating the risks of investment in penny stocks, the possible lack of liquidity, commissions to be paid, current quotation and investors’ rights and remedies, a special suitability inquiry, regular reporting to the investor and other requirements.

Stockholders may not have a vote in approving a business combination. In addition to the recent asset purchase, Valiant intends to enter into other business combinations, in the form of (i) a merger of another company into Valiant, (ii) an acquisition by Valiant of all or substantially all of the stock of another company, or (iii) an acquisition by Valiant of all or substantially all of the assets of another company, structured pursuant to Delaware law in such a manner that generally will not require a vote of stockholders. In such cases stockholders should be aware that they will not have a voice in effecting such a business combination and that Valiant may effect a business combination without prior stockholder consent. Notwithstanding, if under Delaware law any aspect of a business combination requires shareholder vote, Valiant will obtain such vote.

Reporting requirements may delay or preclude business combination. Pursuant to the requirements of Section 13 of the Securities Exchange Act of 1934, as amended, Valiant is required to provide certain information about significant business combinations including audited financial statements of the target company. The additional time and costs that may be incurred by some potential target companies to prepare such financial statements may significantly delay or essentially preclude consummation of an otherwise desirable business combination by Valiant. Target companies that do not have or are unable to obtain the required audited statements may not be appropriate for a business combination so long as the reporting requirements of the Exchange Act are applicable. Notwithstanding a target company’s agreement to obtain audited financial statements within the required time frame, such audited financial statements may not be available to Valiant at the time of entering into an agreement for a business combination. In cases where audited financial statements are unavailable, Valiant will have to rely upon information that has not been verified by outside auditors in making its decision to engage in a transaction with the business entity. This risk increases the prospect that a business combination with such a target company might prove to be an unfavorable one for Valiant.

Regulation under Investment Company Act. In the event Valiant engages in business combinations which result in Valiant holding passive investment interests in a number of entities, Valiant could be subject to regulation under the Investment Company Act of 1940. Passive investment interests, as used in the Investment Company Act, essentially means investments held by entities which do not provide management or consulting services or are not involved in the business whose securities are held. In such event, Valiant would be required to register as an investment company and could be expected to incur significant registration and compliance costs. Valiant has obtained no formal determination from the Securities and Exchange Commission as to the status of Valiant under the Investment Company Act of 1940. Any violation of such Act could subject Valiant to material adverse consequences.

Possible change in value of shares upon business combination. A business combination normally will involve the issuance of a significant number of additional shares. Depending upon the value of the assets acquired in such business combination, the per share value of the common stock of Valiant may increase or decrease, perhaps significantly.

Taxation. Federal and state tax consequences will, in all likelihood, be major considerations in any business combination Valiant may undertake. Currently, such transactions may be structured so as to result in tax-free treatment to both companies, pursuant to various federal and state tax provisions. Valiant intends to structure any business combination so as to minimize the federal and state tax consequences to both Valiant and the target company; however, there can be no assurance that such business combination will meet the statutory requirements of a tax-free reorganization or that the parties will obtain the intended tax-free treatment upon a transfer of stock or assets. A non-qualifying reorganization could result in the imposition of both federal and state taxes which may have an adverse effect on both parties to the transaction.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

~~Valiant has no operations nor does it currently engage in any business activities generating~~General/History ~~revenues. Valiant’s principal business objective for the following 12 months is to achieve long-term growth through a business combination with one or more target companies.~~

Valiant ~~anticipates~~was ~~that~~incorporated ~~during~~under the ~~12 months~~laws ~~following~~of the ~~date~~State of ~~this~~Delaware ~~registration~~on June 24, 2008. During the ~~statement~~following months, itthe ~~will~~only ~~incur~~activities ~~costs~~it ~~related~~conducted was to ~~(i) filing~~file ~~reports~~a asregistration ~~required~~statement bywith the U.S. Securities and Exchange ~~Act~~Commission ~~and (ii)~~on Form ~~consummating~~10, ~~one~~which orbecame ~~more~~effective ~~business~~in ~~combinations~~January 2009. After this event, Valiant ~~anticipates~~is ~~that~~considered a public company with all of the ~~costs~~required reporting requirements under the laws and regulations of ~~seeking~~the SEC, although none of our common stock or other securities ~~investigating~~are listed on a stock exchange or quotation system and ~~analyzing~~thus ~~potential~~are not yet publicly-traded. Valiant was organized to pursue business combinations, ~~over~~particularly in the ~~next~~healthcare ~~12 months~~industry. ~~will~~Until ~~be paid~~its ~~with~~acquisition ~~current~~of ~~funds~~the ordomestic ~~with~~franchise-related ~~such~~assets ~~additional~~of ~~amounts~~Accessible ~~from~~Healthcare ~~the~~Services, ~~sale~~Inc, ofon April 1, ~~its~~2009, ~~securities~~Valiant orconducted ~~that~~no itoperations ~~may~~other than those generally involved in organizing beand ~~able~~the toregistration ~~borrow~~process with the SEC.

On April 1, 2009, Valiant consummated the acquisition of the domestic franchise-related assets of Accessible Healthcare Services, Inc, a Florida corporation, doing business as Accessible Home Health Care. Accessible Healthcare Services, Inc. was incorporated in the State of Florida on May 1, 2003. It began offering for sale franchises that operate under the “Accessible Home Health Care” name and marks on August 1, 2005. Its predecessor company providing home health care services (medical and non-medical) was Accessible Nurse Registry, Inc, which was formed and conducted business since May 2001. This predecessor eventually became a company-owned outlet when it began offering and selling franchises.

Results of Operations

For the three months ending ~~December~~March 31, ~~2008~~2009, Valiant had no activities that produced ~~revenues~~ revenues from operations and incurred no expenses.

For the period from inception (June 24, 2008) through ~~December~~March 31, ~~2008~~2009, Valiant had no activities that produced revenues from operations and had a net loss of $5,000, due to legal, accounting, audit and other professional service fees incurred in relation to the formation of Valiant and the filing of its Registration Statement on ~~From~~ Form 10 filed in November 2008.

Liquidity and Capital Resources

As of ~~December~~March 31, ~~2008~~2009, Valiant had assets equal to $7,500 comprised exclusively of cash. Valiant had current liabilities of $5,000 as of ~~December~~March 31, ~~2008~~2009, comprising accounts payable to professionals.

The following is a summary of Valiant’s cash flows from operating, investing, and financing activities:

For the Cumulative Period from Inception (June 24, 2008) through ~~December~~March 31, ~~2008~~2009


Operating activities	$	—
Investing activities	$	—
Financing activities	$	7,500

Net effect on cash	$	7,500

As of March 31, 2009, Valiant ~~has~~had nominal assets and ~~has~~had generated no revenues since inception. Valiant is also dependent upon the receipt of operating revenues from its recently purchased assets, and capital investment or other financing to fund its ongoing operations and to execute its business plan ~~of seeking a combination with a private operating company~~. If continued funding and capital resources are unavailable at reasonable terms, Valiant may not be able to implement its plan of operations.

Search for Target Company

Valiant does not anticipate utilizing any consultant or finder in locating or analyzing any potential target company. Valiant may seek to locate a target company through solicitation. Such solicitation may include newspaper or magazine advertisements, mailings and other distributions to law firms, accounting firms, investment bankers, financial advisors and similar persons, the use of one or more websites and similar methods. Valiant may also locate a potential target company through its business contacts or others who are aware or become aware of Valiant.

Valiant intends to restrict its search for business entities engaged in the healthcare industry. Such an entity may be in its preliminary or development stage, already in operation, or in essentially any stage of its business life. Valiant believes that there are certain perceived advantages to being a public company such as, among others, increased visibility in the financial community, facilitation of borrowing from financial institutions, possible increased valuation, possible greater ease in raising capital, and enhanced corporate image.

Certain private companies may find a business combination with Valiant more attractive than the public offering of their own securities. Reasons for this may include the following:

• inability to obtain an underwriter; • possible larger costs, fees and expenses of a public offering; • possible delays in the public offering process; • greater dilution of outstanding securities.

Since the effective date of Valiant’s registration statement on Form 10, Valiant has had limited contact or discussions with other entities regarding a potential business combination and there is no assurance that Valiant will locate a target company for a business combination. No assurances can be given that Valiant will be able to enter into any business combination, as to the terms of a business combination, or as to the nature of a target company.

Valiant intends to enter into a business combination, in the form of (i) a merger of another company into Valiant, (ii) an acquisition by Valiant of all or substantially all of the stock of another company, or (iii) an acquisition by Valiant of all or substantially all of the assets of another company, structured pursuant to Delaware law in such a manner that will not require a vote of shareholders. In such cases shareholders should be aware that they will not have a voice in effecting such a business combination and that Valiant may effect a business combination without prior shareholder consent. Notwithstanding if under Delaware law any aspect of a business combination requires shareholder vote, Valiant will obtain such vote.

Once a business combination has been effected, Valiant will file with the Securities and Exchange Commission a report on Form 8-K which will provide disclosure to its shareholders of such transaction.

General Business Plan

~~The~~We ~~purpose~~sell offranchises ~~Valiant~~for isthe right to ~~seek,~~establish ~~investigate~~ and, ifoperate ~~such~~Accessible ~~investigation~~Home ~~warrants~~Health Care franchises, ~~acquire~~which ~~an interest~~is ina ~~one~~home orhealth ~~more~~care ~~business~~(medical ~~entities~~and innon-medical) business under the ~~healthcare~~distinctive format ~~industry.~~and ~~While~~system ~~Valiant~~and ~~will~~marks ~~attempt~~described tobelow (collectively the “Accessible Home Health Care ~~acquire~~franchise” ~~over~~or ~~time~~“franchise”). ~~interests~~As inof ~~more~~the ~~than~~date of this report, we currently operate one ~~such~~company-owned home health care (medical and non-medical) business ~~entity,~~and ithave ~~may~~75 befranchisees. ~~able~~We continue to ~~participate~~offer franchises both nationally and in ~~only~~ ~~one~~some ~~potential~~instances ~~business~~outside ~~venture,~~of ifthe ~~any~~United States, e.g. in ~~part~~Canada ~~because~~and India. ~~Valiant~~Our ~~has~~goal ~~nominal~~is ~~assets~~to ~~and~~have ~~limited financial~~at ~~resources.~~least ~~This~~100 ~~lack~~franchises ofby ~~diversification~~March 31, ~~should~~2010, italthough ~~occur,~~there ~~would~~can be ano guarantee ~~substantial~~that ~~risk~~we will be able to meet this goal given the ~~stockholders~~current state of ~~Valiant~~the ~~because~~U.S. itand international ~~will~~economies ~~not~~and ~~permit~~other ~~Valiant~~factors. toWe ~~offset~~currently ~~potential~~estimate ~~losses~~in ~~from~~our ~~one~~Franchise Disclosure ~~venture~~Document ~~against~~that ~~gains~~prospective ~~from~~franchisees ~~another~~will incur an estimated initial investment of between $88,325 and $98,825 in order to establish and open one franchise.

12Our current franchise fee for one franchise is $41,500 and we offer a discount in the case of multiple franchise purchases. Our franchisees pay us a royalty of 5% of gross sales. Gross sales” is defined in our franchise agreement as all sales of every kind and nature made at or by the franchise less applicable sales or other taxes and refunds and credits made in good faith to arms’ length clients in accordance with our standards and specifications for issuing such refunds or credits. Currently, we bill our franchisees for the royalties on a weekly basis.

~~Table~~In addition to the selling of ~~Contents~~franchises as described above, Valiant is and will continue to seek, investigate and, if such investigation warrants, acquire an interest in one or more other business entities or assets in the healthcare industry.

Valiant may seek a business opportunity with entities which have recently commenced operations, or which wish to utilize the public marketplace in order to raise additional capital in order to expand into new products or markets, to develop a new product or service, or for other corporate purposes.

Valiant believes that as a holding company it offers certain benefits to target companies. The affiliation of multiple companies as part of a holding company may result in cost efficiencies through the reduction of duplicate activities such as administration, office space and advertising. It may result in improved management and product through the interchange of ideas between the various affiliated companies. It may also result in an increased valuation of the holding company beyond the combined valuations of the affiliated companies separately.

~~Valiant intends at some point to become a publicly-traded company by the registration of its~~13 securities. This will not occur until Valiant has entered into at least one business combination. Valiant also intends from time to time to seek financing for its activities through debt or equity offerings, or both. No assurance can be given that Valiant will be able to enter into any business combination, to have its securities publicly traded, or to obtain debt or equity financing.

TargetTable companies may include those seeking the perceived benefits of a publicly-traded company. Such perceived benefits may include facilitating or improving the terms on which debt or equity financing may be sought, providing liquidity for incentive stock options or similar benefits to key employees, providing liquidity for stockholders and other factors. Business opportunities may be available in many different parts of the healthcare industry and at various stages of development, all of which will make the task of comparative investigation and analysis of such business opportunities difficult and complex. Contents

Valiant ~~has,~~intends ~~and~~from ~~will~~time ~~continue~~ to ~~have,~~time noto ~~capital~~seek ~~itself~~financing ~~with~~for ~~which~~its toactivities ~~provide~~through ~~the~~debt ~~owners~~or ofequity ~~business~~offerings, ~~entities with any cash~~ or ~~other assets~~both. ~~Any~~No ~~capital~~assurance ~~formation~~can ~~for~~be ~~such~~given ~~business~~that ~~entities would occur after the business combination. While in certain cases~~ Valiant ~~may~~will ~~structure~~be ~~a commitment~~able ~~from a underwriter or other financial source for funding incident~~ to orenter ~~following~~into ~~a business~~any business combination, itto ishave ~~more~~its ~~likely~~securities ~~that~~publicly ~~such a commitment will not exist. In such case~~traded, ~~a target~~or ~~company for which financing is a consideration would have~~ to ~~decide~~obtain ~~whether~~debt toor ~~enter~~equity ~~into a business combination without any assurance of such~~ financing.

The analysis of new business opportunities will be undertaken by, or under the supervision of, the ~~officer~~officers and ~~director~~directors of Valiant. In analyzing prospective business opportunities, Valiant may consider such matters as the available technical, financial and managerial resources; working capital and other financial requirements; history of operations, if any; prospects for the future; nature of present and expected competition; the quality and experience of management services which may be available and the depth of that management; the potential for further research, development, or exploration; specific risk factors not now foreseeable but which may be anticipated; the potential for growth or expansion; the potential for profit; the perceived public recognition or acceptance of products, services, or trades; name identification; and other relevant factors. This discussion of the proposed criteria is not meant to be restrictive of the virtually unlimited discretion of Valiant to search for and enter into potential additional business opportunities.

Valiant is subject to the reporting requirements of the Exchange Act. Included in these requirements is the duty of Valiant to file audited financial statements reporting a business combination which is required to be filed with the Securities and Exchange Commission upon completion of the combination.

Search for Other Targets

Valiant does not anticipate utilizing any consultant or finder in locating or analyzing additional potential target entities or the assets of these entities. Valiant may seek to locate a target company through solicitation. Such solicitation may include newspaper or magazine advertisements, mailings and other distributions to law firms, accounting firms, investment bankers, financial advisors and similar persons, the use of one or more websites and similar methods. Valiant may also locate a potential target entities or the assets of these entities through its business contacts or others who are aware or become aware of Valiant.

Valiant intends to restrict its search for business entities or assets engaged in the healthcare industry. Such an entity may be in its preliminary or development stage, already in operation, or in essentially any stage of its business life. Valiant believes that there are certain perceived advantages to being a public company such as, among others, increased visibility in the financial community, facilitation of borrowing from financial institutions, possible increased valuation, possible greater ease in raising capital, and enhanced corporate image.

Certain private companies may find a business combination with Valiant more attractive than the public offering of their own securities. Reasons for this may include the following:

•

inability to obtain an underwriter;

•

possible larger costs, fees and expenses of a public offering;

•

possible delays in the public offering process;

•

greater dilution of outstanding securities.

Since the effective date of Valiant’s registration statement on Form 10, Valiant has consummated one asset purchase from an entity with similar ownership. In addition, we recently signed a non-binding letter of intent with a durable medical equipment provider located in south Florida. We are currently conducting a legal and financial due diligence investigation on such entity and, assuming that such investigation concludes without any material issues that cannot be resolved, we hope to consummate the transaction by the end of June 2009. No assurances can be given that Valiant will be able to consummate the transaction with the durable medical equipment entity or enter into any other business combination.

Terms of a Business Combination

In implementing a structure for a particular business combination, Valiant may become a party to a merger, consolidation, reorganization, joint venture, licensing agreement or other arrangement with another corporation or entity.

It is anticipated that any securities issued in any such business combination would be issued in reliance upon exemption from registration under applicable federal and state securities laws. In many circumstances, Valiant may wish to register all or a part of its securities for public trading after the transaction is consummated. If such registration occurs, it will be undertaken after Valiant has entered into an agreement for a business combination or has consummated a business combination and Valiant is no longer considered a blank check company. The issuance of additional securities and their potential sale into any trading market which may develop in the securities of Valiant may depress the market value of the securities of Valiant in the future if such a market develops, of which there is no assurance.

While the terms of a business transaction to which Valiant may be a party cannot be predicted, it is expected that the parties to the business transaction will desire to avoid the creation of a taxable event and will thereby attempt to structure the combination as a tax-free reorganization under Sections 351 or 368 of the Internal Revenue Code of 1986, as amended.

Valiant will participate in a business combination only after the negotiation and execution of appropriate agreements. Although the terms of such agreements cannot be predicted, generally such agreements will require certain representations and warranties of the parties thereto, will specify certain events of default, will detail the terms of closing and the conditions which must be satisfied by the parties prior to and after such closing and will include miscellaneous other terms.

Undertakings and Understandings Required of Target Companies

A potential target company should be aware that the market price and trading volume of the securities of Valiant, when and if listed for secondary trading, may depend in great measure upon the efforts of management to encourage interest in Valiant within the United States financial community. Valiant does not have currently the market support of an underwriter that would normally follow a public offering of its securities. Initial market makers are likely to simply post bid and asked prices and are unlikely to take positions in Valiant’s securities for their own account or customers without active encouragement and a basis for doing so. In addition, certain market makers may take short positions in Valiant’s securities, which may result in a significant pressure on their market price. Valiant may consider the ability and commitment of a target company to participate with management in actively encouraging interest in Valiant’s securities following a business combination in deciding whether to enter into a transaction with such company.

A business combination with Valiant separates the process of becoming a public company from the raising of investment capital. As a result, a business combination with Valiant normally will not be a beneficial transaction for a target company whose primary reason for becoming a public company is the immediate infusion of capital. Valiant may require assurances from the target company that it has or that it has a reasonable belief that it will have sufficient sources of capital to continue operations following the business combination. However, it is possible that a target company may give such assurances in error, or that the basis for such belief may change as a result of circumstances beyond the control of the target company.

Competition

~~Valiant~~While ~~will~~we ~~remain~~believe anthat ~~insignificant~~the ~~participant~~market ~~among~~for ~~the~~home ~~firms~~health ~~which~~care ~~engage~~services in(medical ~~business~~and non-medical) is ~~combinations~~not ~~and~~yet ~~seeking~~fully ~~business~~developed, ~~opportunities~~it is highly competitive. ~~There~~We ~~are~~and ~~many~~our ~~established~~franchisees ~~venture~~compete ~~capital~~with ~~and~~other ~~financial~~local, ~~concerns~~regional ~~which~~and ~~have~~national ~~significantly~~home ~~greater~~health ~~financial~~care ~~and~~businesses ~~personnel~~offering ~~resources~~similar ~~and~~services. ~~technical~~We believe ~~expertise~~that ~~than~~the ~~Valiant.~~marketing Indifferentiation ~~view~~for ofour ~~Valiant’s~~business ~~combined~~is ~~extremely~~our ~~limited~~network ~~financial~~of ~~resources~~national ~~and~~referral prospects, ~~limited~~direct ~~management availability~~advertising, ~~Valiant~~and ~~will~~proven ~~continue~~marketing toprogram. ~~beat~~Some aof ~~significant~~our ~~competitive~~competitors include Brightstar, Right ~~disadvantage~~at ~~compared~~Home, toComfort ~~Valiant’s~~Keepers, ~~competitors~~Visiting Angels, Home Instead and Homewatch.

1415

Valiant will also remain an insignificant participant among the firms which engage in business combinations and seeking business opportunities. There are many established venture capital and financial concerns which have significantly greater financial and personnel resources and technical expertise than Valiant. In view of Valiant’s combined extremely limited financial resources and limited management availability, Valiant will continue to be at a significant competitive disadvantage compared to Valiant’s competitors.

Off-Balance Sheet Arrangements

Valiant does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, Valiant is not required to provide information by this Item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer (which currently is the same person), we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and Rule 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (Exchange Act), as of September 30, 2008. Based on this evaluation, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that our disclosure and controls are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes (including corrective actions with regard to significant deficiencies or material weaknesses) in our internal controls over financial reporting that occurred during the ~~third~~ quarter ended ~~December~~March 31, ~~2008~~2009 that has materially affected, or is reasonably likely to ~~materially~~ materially affect, our internal control over financial reporting.

1516

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Valiant is not involved in any material legal proceedings as of the date of this report.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

(a) Exhibits


	31.1			Certification of President pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

	32			Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

(b) Reports on Form 8-K

None during the quarter ended March 31, 2009.

1617

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: ~~March~~May 37, 2009


	VALIANT HEALTHCARE, INC. (Registrant)
	By:	/s/ Steven Turner
		Steven Turner
		President (Principal Executive Officer and Chief Accounting Officer)

1718

EXHIBIT INDEX

	31.1	Certification of President pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit
	32	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
No.		Description
	31.1	CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
	32	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

1819

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Filing Compare · Valiant ACMS, Inc.